Search This Blog

Tuesday, August 7, 2018

Gemphire Therapeutics cut to Neutral from Outperform at Raymond James


Gemphire Therapeutics downgraded to Market Perform from Outperform at Raymond James

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)